AI in medicine is transforming healthcare by enhancing rapid diagnoses, imaging analytics, and personalized care plans, contributing to significant market growth. The global AI healthcare market was valued at approximately USD 26.57 billion in 2024, with projections reaching $187.69 billion by 2030, highlighting a robust CAGR of 38.62%. North America is leading the charge, holding over 54% of the market, driven by demands for improved efficiency and patient outcomes.
Key trends include software solutions commanding over 46% of revenue in 2024, while the robot-assisted surgery sector accounted for over 13%. Machine learning technologies dominated, exceeding 35% market share.
Experts like Dr. James C. Wittig emphasize AI’s potential to enhance tumor diagnosis accuracy, enabling rapid analysis of medical images for early detection. AI systems also facilitate automated second opinions and personalized treatment plans, demonstrating their transformative role in oncology and paving the way for future medical advancements.
Source link
